Real World Experience of Letermovir (LTV) Prophylaxis (Px) for the Prevention of Cytomegalovirus Infection (CMVi) in the Adult CMV Seropositive Recipients (R+) of Allogeneic Hematopoietic Cell Transplantation (HCT) Patients (pts).
Sign Up to like & getrecommendations! Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.590
Abstract: CMVi leads to significant morbidity in R+ HCT and preemptive therapy (PET) has been the standard of care. LTV was FDA-approved in Nov. 2017 for CMVi prevention in R+ HCT. Besides the clinical trials, there… read more here.
Keywords: risk; ltv; hct; cmvi ... See more keywords
Tracking Control Based on Model Predictive Control Using Laguerre Functions With Pole Optimization
Sign Up to like & getrecommendations! Published in 2022 at "IEEE Transactions on Intelligent Transportation Systems"
DOI: 10.1109/tits.2022.3179613
Abstract: This paper focused on improving a model predictive control (MPC) using Laguerre functions. This study was conducted to achieve high performance while reducing the computational complexity of MPC for autonomous vehicle tracking control. Previous studies… read more here.
Keywords: using laguerre; laguerre functions; control; ltv ... See more keywords
Real World Outcomes of Letermovir Prophylaxis in Unselected High Risk CMV Seropositive Hematopoietic Stem Cell Transplant Recipients
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-131365
Abstract: Introduction: Cytomegalovirus (CMV) is a leading cause of morbidity following allogenenic hematopoietic stem cell transplant (HSCT). Letermovir (LTV), an orally available antiviral drug which inhibits the CMV-terminase complex, was recently approved for CMV prophylaxis in… read more here.
Keywords: prophylaxis; risk; ltv; cmv infection ... See more keywords